Detalhe da pesquisa
1.
[Heart and cancer: cardio-oncology]. / Herz und Krebs: Kardioonkologie.
Herz
; 49(2): 111-117, 2024 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-38289420
2.
[Update cardio-oncology : Immune checkpoint inhibitor therapy]. / Update Kardioonkologie : Immuncheckpoint-Inhibitor-Therapie.
Herz
; 49(1): 81-90, 2024 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-38175285
3.
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction.
Curr Heart Fail Rep
; 21(3): 214-223, 2024 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430308
4.
Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment.
Curr Heart Fail Rep
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809394
5.
(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis.
Curr Heart Fail Rep
; 21(3): 224-237, 2024 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635117
6.
[2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy]. / ESC-Leitlinie 2022 onkologische Kardiologie : Kardiovaskuläre Nebenwirkungen durch Krebstherapie verstehen und behandeln.
Herz
; 48(1): 15-22, 2023 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-36441175
7.
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies.
Eur Heart J
; 43(20): 1928-1940, 2022 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35257157
8.
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy.
Eur Heart J
; 43(4): 316-329, 2022 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34389849
9.
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart.
Int J Mol Sci
; 24(7)2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047026
10.
PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial Infarction.
Int J Mol Sci
; 23(14)2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35886878
11.
Oncocardiology: new challenges, new opportunities.
Herz
; 45(7): 619-625, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32514587
12.
Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system.
Herz
; 45(7): 645-651, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533218
13.
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity.
Basic Res Cardiol
; 116(1): 62, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671866
14.
High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy.
Clin Res Cardiol
; 113(2): 301-312, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955712
15.
Detectable troponin below the 99th percentile predicts survival in patients undergoing coronary angiography.
Int J Cardiol Heart Vasc
; 52: 101419, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38725439
16.
Frequency and prognosis of CVD and myocardial injury in patients presenting with suspected COVID-19 - The CoV-COR registry.
Int J Cardiol Heart Vasc
; 45: 101184, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776683
17.
[Drug-induced cardiomyopathies]. / Medikamentös bedingte Kardiomyopathien.
Dtsch Med Wochenschr
; 147(23): 1513-1522, 2022 11.
Artigo
em Alemão
| MEDLINE | ID: mdl-36384152
18.
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy.
ESC Heart Fail
; 9(5): 3533-3542, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894541
19.
Assessment of coronary artery disease during hospitalization for cancer treatment.
Clin Res Cardiol
; 110(2): 200-210, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32743679
20.
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis.
ESC Heart Fail
; 7(2): 423-433, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32069386